title: Neonatal outcome and obstetric complications in women with gestational diabetes: effects of maternal body mass index.
abstract: OBJECTIVE
  To evaluate in a selected population the clinical characteristics (time of diagnosis, different treatment, metabolic parameters, etc.) of gestational diabetes in relation to prepregnancy body mass index (BMI) and the influence of BMI on neonatal outcome.
  
  
  METHODS
  This study was retrospectively led using a computerized data system for all deliveries that occurred at the Departments of Obstetrics and Gynecology of the University of Pisa (Italy) from 1 January 1987 to 31 December 1992.
  
  
  METHODS
  93 women with GDM and 110 control subjects divided into three groups according to their pre-pregnancy BMI: normal weight (Nw), overweight (Ow) and obese (Ob).
  
  
  METHODS
  Time of diagnosis, mode of treatment and metabolic control of GDM; time and mode of delivery, neonatal outcome (macrosomia, respiratory distress syndrome, hyperbilirubinemia, hypoglycemia, polycythemia, hypocalcemia).
  
  
  RESULTS
  GDM was diagnosed earlier in Ow and Ob than in Nw (p < 0.01) and insulin treatment was used in 86% of Ob-GDM, 91% of Ow-GDM and in 77% of Nw-GDM women (p < 0.001). Preterm deliveries and cesarean sections resulted significantly increased in all BMI categories of GDM patients with respect to matched normal controls. Prevalence of neonatal macrosomia was higher in GDM patients (44.6%) compared with normal controls (15.4%) and correlated (p > 0.01) with prepregnancy BMI in both groups. The body weight increase during pregnancy was not associated with neonatal macrosomia.
  
  
  CONCLUSIONS
  The degree of overweight is associated with an earlier diagnosis of GDM; prepregnancy BMI is more predictive of macrosomia than weight gain, both in control and GDM women; GDM seems to play the most important role in increasing the possibility of the occurrence of macrosomia.
authors.affiliation: Department of Metabolic Disease, Institute of Clinical Medicine II, University of Pisa, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Di Cianni
authors.forename: L
authors.initials: L
authors.lastname: Benzi
authors.forename: P
authors.initials: P
authors.lastname: Bottone
authors.forename: L
authors.initials: L
authors.lastname: Volpe
authors.forename: P
authors.initials: P
authors.lastname: Orsini
authors.forename: S
authors.initials: S
authors.lastname: Murru
authors.forename: I
authors.initials: I
authors.lastname: Casadidio
authors.forename: F
authors.initials: F
authors.lastname: Clemente
authors.forename: R
authors.initials: R
authors.lastname: Navalesi
mesh_terms: D015992:Body Mass Index; D016640:Diabetes, Gestational / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005320:Fetal Macrosomia / Q000209:etiology; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology; D007231:Infant, Newborn; D007328:Insulin / Q000627:therapeutic use; D011247:Pregnancy; D011256:Pregnancy Outcome; D015430:Weight Gain
chemical_list: D007328:Insulin